The BC Platforms podcast series, ‘From data to health’ brings together innovators representing the ecosystem of users, custodians, contributors of healthcare data. This series is hosted by Dr. Tonu Esko, head of the Estonian Biobank Innovation Center. Each guest sheds light on how they advance and envision the future of health through data.
BC Platforms Podcast
Claim This Podcastby BC Platforms
5.0(3 reviews)
7 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇪🇪
Podcast Overview
The BC Platforms podcast series, ‘From data to health’ brings together innovators representing the ecosystem of users, custodians, contributors of healthcare data. This series is hosted by Dr. Tonu Esko, head of the Estonian Biobank Innovation Center. Each guest sheds light on how they advance and envision the future of health through data.
Language
🇺🇲
Publishing Since
4/29/2021
1 verified contact email on file for BC Platforms Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
September 6, 2023
007 AI & Real World Data - Advancing Cancer Research and Care through the ONCOVALUE initiative
<p>Dr. Carolin Bender, Chief Medical Officer for BC Platforms speaks with On Air Media Group about the groundbreaking ONCOVALUE project in collaboration with Helsinki University Hospital (HUS) and other European institutions, that seeks to explore and leverage real-world data (RWD) in the context of cancer research and treatment, and it's dedication to developing an AI-based framework that assesses the real-time, real-life effectiveness of novel cancer therapies.</p>
May 25, 2021
006 Using Genomics to Accelerate Drug Development
<p><span style="font-weight: 400;">Today's episode will focus on the topic of using genomics to accelerate drug development. </span></p> <p><span style="font-weight: 400;">Our host is Tõnu Esko, BC Platforms SAB Chairman and Vice Director of the Institute of Genomics University of Tartu, where he also holds a Professor of Human Genomics position. He is head of the Estonian Biobank Innovation Center and focuses on public private partnerships and innovation transfer. Dr. Esko is also a research scientist at the Broad Institute of Harvard at MIT. He acts as one of the senior leaders for Estonian personalized medicine programs and serves as a scientific advisor for several companies. </span></p> <p><span style="font-weight: 400;">Our guest today is Iris Grossman, on the leading edge of Personalized Medicine, Big Data Analytics and Biotech R&D for 20 years. She is Acting CSO of Amide and advises other biotech in her field of expertise. She has held leadership positions and or consulted for top big pharma GSK, Eli Lilly, Takeda and Teva, where she was VP Head of early stage development, startup and consultancies. She specializes in leveraging high dimensional genomic insights and E-health as engines of therapeutic discovery, development and Lifecycle Management across a wide range of modalities and therapeutic areas. Iris also serves as SAB member of BC platforms, Tipa Biobank, Eleven Therapeutics and CGRP Diagnostics. She earned her B.Sc. in Medicine at the Technion, and a PhD in Medicine, Population Genomics and Pharmacogenomics for the Technion, co-mentored with the Weitzman Institute. Next, she was a postdoc fellow in Personalized Medicine and Population Genomics at Duke University.</span></p> <p>What is covered:</p> <p><span style="font-weight: 400;">- The benefits of using big data in drug discovery</span></p> <p><span style="font-weight: 400;">- Specific examples of how the genetics could be helpful in the drug discovery, such as the contribution of human genetics and genomics to fighting COVID</span></p> <p><span style="font-weight: 400;">- The recommendations to stakeholders for collaborating within the industry for the sake of innovation </span></p> <p><span style="font-weight: 400;">- How biobanks can potentially act as middlemen for this new type of collaboration</span></p> <p>Resources:</p> <p><span style="font-weight: 400;">- The Institute of Genomics, University of Tartu</span> <a href= "https://genomics.ut.ee/en"><span style= "font-weight: 400;">https://genomics.ut.ee/en</span></a></p> <p><span style="font-weight: 400;">- The Estonian Biobank</span> <a href="https://genomics.ut.ee/en"><span style= "font-weight: 400;">https://genomics.ut.ee/en</span></a><span style="font-weight: 400;"> </span></p> <p><span style="font-weight: 400;">- Amide Technologies</span> <a href="https://www.amidetech.com/"><span style= "font-weight: 400;">https://www.amidetech.com/</span></a></p> <p><span style="font-weight: 400;">- GSK</span> <a href= "https://www.gsk.com/"><span style= "font-weight: 400;">https://www.gsk.com/</span></a></p> <p><span style="font-weight: 400;">- Eli Lilly</span> <a href= "https://www.lilly.com/"><span style= "font-weight: 400;">https://www.lilly.com/</span></a></p> <p><span style="font-weight: 400;">- Takeda</span> <a href= "https://www.takeda.com/"><span style= "font-weight: 400;">https://www.takeda.com/</span></a></p> <p><span style="font-weight: 400;">- Teva Pharmaceutical</span> <a href="https://www.tevapharm.com/"><span style= "font-weight: 400;">https://www.tevapharm.com/</span></a></p> <p><span style="font-weight: 400;">- Tipa Biobank</span> <a href= "https://www.ksminnovation.com/biobank"><span style= "font-weight: 400;">https://www.ksminnovation.com/biobank</span></a></p> <p><span style="font-weight: 400;">- Eleven Therapeutics</span> <a href="https://eleventx.com/"><span style= "font-weight: 400;">https://eleventx.com/</span></a></p> <p><span style="font-weight: 400;">- CGRP Diagnostics</span> <a href="http://cgrpdiagnostics.com/"><span style= "font-weight: 400;">http://cgrpdiagnostics.com/</span></a></p> <p>Connect with Iris Grossman:</p> <p>- <a href= "https://www.linkedin.com/in/irisgrossman/"><span style= "font-weight: 400;">https://www.linkedin.com/in/irisgrossman/</span></a></p> <p>Connect with Dr. Tõnu Esko: </p> <p>- <a href= "https://www.linkedin.com/in/t%C3%B5nu-esko-24511524/"><span style= "font-weight: 400;">https://www.linkedin.com/in/tõnu-esko-24511524/</span></a><span style="font-weight: 400;"> </span></p> <p>Connect with BC Platforms: </p> <p>- <a href="https://www.bcplatforms.com"><span style= "font-weight: 400;">https://www.bcplatforms.com</span></a><span style="font-weight: 400;"> </span></p> <p>- <a href= "https://www.linkedin.com/company/bc-platforms/"><span style= "font-weight: 400;">https://www.linkedin.com/company/bc-platforms/</span></a><span style="font-weight: 400;"> </span></p> <p>- <a href="mailto:sales@bcplatforms.com"><span style= "font-weight: 400;">sales@bcplatforms.com</span></a><span style= "font-weight: 400;"> </span></p>
May 18, 2021
005 Accelerated Insights From Data for Preventative Health Innovation
<p><span style="font-weight: 400;">Today's podcast will focus on the topic of accelerated insights from data for preventative health innovation. The podcast sheds light on industry challenges and expectations as well as innovative approaches to collaboration. </span></p> <p><span style="font-weight: 400;">This discussion is led by Tõnu Esko, BC Platforms SAB Chairman and Vice Director of the Institute of Genomics University of Tartu, where he also holds a Professor of Human Genomics position. He is head of the Estonian Biobank Innovation Center and focuses on public private partnerships and innovation transfer. Dr. Esko is also a research scientist at the Broad Institute of Harvard at MIT. He acts as one of the senior leaders for Estonian personalized medicine programs and serves as a scientific advisor for several companies. </span></p> <p><span style="font-weight: 400;">Our speaker today is Michael Geer, the co-founder of Humanity along with Peter Ward. Humanity is a health tech startup that enables you to find your rate of aging, and do what you can do to slow your aging down. Michael Geer is a serial tech entrepreneur, having amassed over a billion users with Badoo, AnchorFree, and even more revenue over his years building meaningful consumer focused technology. He wakes up every day working on how to best enable people with superpowers. </span></p> <p><strong>What is Covered:</strong></p> <p><span style="font-weight: 400;">- What are the main obstacles to innovation in healthcare</span></p> <p><span style="font-weight: 400;">- How to open the access to different data types, and leverage this knowledge in order to build a complex health guide</span></p> <p><span style="font-weight: 400;">- The importance of democratization of data, federated access, and differential privacy in making data readily usable by other people</span></p> <p><span style="font-weight: 400;">- What scientific insights Humanity uses to build their products</span></p> <p><span style="font-weight: 400;">- How Humanity manages the complexity of its data model, and the feedback it provides to their customers</span></p> <p><strong>Resources:</strong></p> <p><span style="font-weight: 400;">- The Institute of Genomics, University of Tartu</span> <a href= "https://genomics.ut.ee/en"><span style= "font-weight: 400;">https://genomics.ut.ee/en</span></a></p> <p><span style="font-weight: 400;">- The Estonian Biobank</span> <a href="https://genomics.ut.ee/en"><span style= "font-weight: 400;">https://genomics.ut.ee/en</span></a><span style="font-weight: 400;"> </span></p> <p><span style="font-weight: 400;">- Humanity</span> <a href= "https://www.humanity.health/"><span style= "font-weight: 400;">https://www.humanity.health/</span></a></p> <p><span style="font-weight: 400;">- OpenMind</span> <a href= "https://openmindplatform.org/"><span style= "font-weight: 400;">https://openmindplatform.org/</span></a></p> <p><span style="font-weight: 400;">- BioAge Labs</span> <a href= "https://bioagelabs.com/"><span style= "font-weight: 400;">https://bioagelabs.com/</span></a></p> <p><strong>Connect with Michael Geer:</strong></p> <p>- <a href="https://www.linkedin.com/in/michaelgeer"><span style= "font-weight: 400;">https://www.linkedin.com/in/michaelgeer</span></a></p> <p><strong>Connect with Dr. Tõnu Esko: </strong></p> <p>- <a href= "https://www.linkedin.com/in/t%C3%B5nu-esko-24511524/"><span style= "font-weight: 400;">https://www.linkedin.com/in/tõnu-esko-24511524/</span></a><span style="font-weight: 400;"> </span></p> <p><strong>Connect with BC Platforms: </strong></p> <p>- <a href="https://www.bcplatforms.com"><span style= "font-weight: 400;">https://www.bcplatforms.com</span></a><span style="font-weight: 400;"> </span></p> <p>- <a href= "https://www.linkedin.com/company/bc-platforms/"><span style= "font-weight: 400;">https://www.linkedin.com/company/bc-platforms/</span></a><span style="font-weight: 400;"> </span></p> <p>- <a href="mailto:sales@bcplatforms.com"><span style= "font-weight: 400;">sales@bcplatforms.com</span></a><span style= "font-weight: 400;"> </span></p>
7 total episodes available
Deep-dive analytics for BC Platforms Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is BC Platforms Podcast?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.